OIG - Office of Inspector General
10/10/2024 | Press release | Distributed by Public on 10/10/2024 14:17
Teva Pharmaceuticals Agrees To Pay $425 Million To Resolve Kickback Allegations
Teva Pharmaceuticals Agrees To Pay $425 Million To Resolve Kickback Allegations
Settlement resolves allegations that the company funneled kickbacks through co-pay assistance foundations
BOSTON - Teva Pharmaceuticals USA, Inc. and Teva Neuroscience, Inc. (collectively Teva) have agreed to pay $425 million to resolve allegations that Teva paid kickbacks via two co-pay assistance foundations in violation of the Anti-Kickback Statute (AKS) and False Claims Act.
Action Details
- Date:October 10, 2024
- Agency:U.S. Attorney's Office, District of Massachusetts
-
Enforcement Types:
- Criminal and Civil Actions
Share